Guizhou Xinbang Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice
Guizhou Xinbang Pharmaceutical: 002390 Xinbang Pharmaceutical Investor Relations Management Information 20240509
Guizhou Xinbang Pharmaceutical: Announcement of the resolution of the 2023 Annual General Meeting of Shareholders
Guizhou Xinbang Pharmaceutical: Legal Opinion of Guohao Law Firm (Shanghai) on the 2023 Annual General Meeting of Shareholders of Guizhou Xinbang Pharmaceutical Co., Ltd.
Guizhou Xinbang Pharmaceutical: Announcement on the progress of the repurchase of company shares
Guizhou Xinbang Pharmaceutical: Announcement on the pledge of some of the shares of the controlling shareholder
Guizhou Xinbang Pharmaceutical: Announcement on the progress of litigation matters
Guizhou Xinbang Pharmaceutical: Announcement on participating in the Investor Group Reception Day event and the 2023 Annual Results Briefing
Guizhou Xinbang Pharmaceutical: 2024 First Quarter Report
Xinbang Pharmaceuticals: 002390 Xinbang Pharmaceuticals Investor Relations Management Information 20240416
Xinbang Pharmaceutical: Notice of Annual General Meeting of Shareholders
Xinbang Pharmaceuticals: 2023 Annual Audit Report
Xinbang Pharmaceutical: Announcement of Board Resolutions
Xinbang Pharmaceutical: Internal Control Self-Evaluation Report
Xinbang Pharmaceutical: 2023 Independent Director Debriefing Report (Dong Yanan - Resignation)
Xinbang Pharmaceutical: Announcement on the Appointment of the Company's 2024 Auditor
Xinbang Pharmaceutical: 2023 Board Work Report
Xinbang Pharmaceutical: Report of the Board of Directors and Audit Committee on the Evaluation of the Performance of Accounting Firms in 2023
Xinbang Pharmaceuticals: 2023 Annual Report
Xinbang Pharmaceutical: Announcement of Supervisory Board Resolutions
No Data